MTC eHealth DSI [eHDSI v2.2.1] European Commission - Master Translation/Transcoding Catalogue Responsible : eHDSI Solution Provider PublishDate : Thu Jun 01 17:03:48 CEST 2017 © eHealth DSI eHDSI Solution Provider v2.2.1 Thu Jun 01 17:03:48 CEST 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.1 Thu Jun 01 17:03:48 CEST 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.1 Thu Jun 01 17:03:48 CEST 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01 A01 STOMATOLOGICAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 A01A STOMATOLOGICAL PREPARATIONS 2.16.840.1.113883.6.73 2017-01 A01AA Caries prophylactic agents 2.16.840.1.113883.6.73 2017-01 A01AA01 sodium fluoride 2.16.840.1.113883.6.73 2017-01 A01AA02 sodium monofluorophosphate 2.16.840.1.113883.6.73 2017-01 A01AA03 olaflur 2.16.840.1.113883.6.73 2017-01 A01AA04 stannous fluoride 2.16.840.1.113883.6.73 2017-01 A01AA30 combinations 2.16.840.1.113883.6.73 2017-01 A01AA51 sodium fluoride, combinations 2.16.840.1.113883.6.73 2017-01 A01AB Antiinfectives and antiseptics for local oral treatment 2.16.840.1.113883.6.73 2017-01 A01AB02 hydrogen peroxide 2.16.840.1.113883.6.73 2017-01 A01AB03 chlorhexidine 2.16.840.1.113883.6.73 2017-01 A01AB04 amphotericin B 2.16.840.1.113883.6.73 2017-01 A01AB05 polynoxylin 2.16.840.1.113883.6.73 2017-01 A01AB06 domiphen 2.16.840.1.113883.6.73 2017-01 A01AB07 oxyquinoline 2.16.840.1.113883.6.73 2017-01 A01AB08 neomycin 2.16.840.1.113883.6.73 2017-01 A01AB09 miconazole 2.16.840.1.113883.6.73 2017-01 A01AB10 natamycin 2.16.840.1.113883.6.73 2017-01 A01AB11 various 2.16.840.1.113883.6.73 2017-01 A01AB12 hexetidine 2.16.840.1.113883.6.73 2017-01 A01AB13 tetracycline 2.16.840.1.113883.6.73 2017-01 A01AB14 benzoxonium chloride 2.16.840.1.113883.6.73 2017-01 A01AB15 tibezonium iodide 2.16.840.1.113883.6.73 2017-01 A01AB16 mepartricin 2.16.840.1.113883.6.73 2017-01 A01AB17 metronidazole 2.16.840.1.113883.6.73 2017-01 A01AB18 clotrimazole 2.16.840.1.113883.6.73 2017-01 A01AB19 sodium perborate 2.16.840.1.113883.6.73 2017-01 A01AB21 chlortetracycline 2.16.840.1.113883.6.73 2017-01 A01AB22 doxycycline 2.16.840.1.113883.6.73 2017-01 A01AB23 minocycline © eHealth DSI eHDSI Solution Provider v2.2.1 Thu Jun 01 17:03:48 CEST 2017 Page 4 of 490 MTC epSOSActiveIngredient 2.16.840.1.113883.6.73 2017-01 A01AC Corticosteroids for local oral treatment 2.16.840.1.113883.6.73 2017-01 A01AC01 triamcinolone 2.16.840.1.113883.6.73 2017-01 A01AC02 dexamethasone 2.16.840.1.113883.6.73 2017-01 A01AC03 hydrocortisone 2.16.840.1.113883.6.73 2017-01 A01AC54 prednisolone, combinations 2.16.840.1.113883.6.73 2017-01 A01AD Other agents for local oral treatment 2.16.840.1.113883.6.73 2017-01 A01AD01 epinephrine 2.16.840.1.113883.6.73 2017-01 A01AD02 benzydamine 2.16.840.1.113883.6.73 2017-01 A01AD05 acetylsalicylic acid 2.16.840.1.113883.6.73 2017-01 A01AD06 adrenalone 2.16.840.1.113883.6.73 2017-01 A01AD07 amlexanox 2.16.840.1.113883.6.73 2017-01 A01AD08 becaplermin 2.16.840.1.113883.6.73 2017-01 A01AD11 various 2.16.840.1.113883.6.73 2017-01 A02 DRUGS FOR ACID RELATED DISORDERS 2.16.840.1.113883.6.73 2017-01 A02A ANTACIDS 2.16.840.1.113883.6.73 2017-01 A02AA Magnesium compounds 2.16.840.1.113883.6.73 2017-01 A02AA01 magnesium carbonate 2.16.840.1.113883.6.73 2017-01 A02AA02 magnesium oxide 2.16.840.1.113883.6.73 2017-01 A02AA03 magnesium peroxide 2.16.840.1.113883.6.73 2017-01 A02AA04 magnesium hydroxide 2.16.840.1.113883.6.73 2017-01 A02AA05 magnesium silicate 2.16.840.1.113883.6.73 2017-01 A02AA10 combinations 2.16.840.1.113883.6.73 2017-01 A02AB Aluminium compounds 2.16.840.1.113883.6.73 2017-01 A02AB01 aluminium hydroxide 2.16.840.1.113883.6.73 2017-01 A02AB02 algeldrate 2.16.840.1.113883.6.73 2017-01 A02AB03 aluminium phosphate 2.16.840.1.113883.6.73 2017-01 A02AB04 dihydroxialumini sodium carbonate 2.16.840.1.113883.6.73 2017-01 A02AB05 aluminium acetoacetate 2.16.840.1.113883.6.73 2017-01 A02AB06 aloglutamol 2.16.840.1.113883.6.73 2017-01 A02AB07 aluminium glycinate 2.16.840.1.113883.6.73 2017-01 A02AB10 combinations 2.16.840.1.113883.6.73 2017-01 A02AC Calcium compounds 2.16.840.1.113883.6.73 2017-01 A02AC01 calcium carbonate 2.16.840.1.113883.6.73 2017-01 A02AC02 calcium silicate 2.16.840.1.113883.6.73 2017-01 A02AC10 combinations 2.16.840.1.113883.6.73 2017-01 A02AD Combinations and complexes of aluminium, calcium and magnesium compounds 2.16.840.1.113883.6.73 2017-01 A02AD01 ordinary salt combinations 2.16.840.1.113883.6.73 2017-01 A02AD02 magaldrate 2.16.840.1.113883.6.73 2017-01 A02AD03 almagate 2.16.840.1.113883.6.73 2017-01 A02AD04 hydrotalcite 2.16.840.1.113883.6.73 2017-01 A02AD05 almasilate 2.16.840.1.113883.6.73 2017-01 A02AF Antacids with antiflatulents © eHealth DSI eHDSI Solution Provider v2.2.1 Thu Jun 01 17:03:48 CEST 2017 Page 5 of 490 MTC epSOSActiveIngredient 2.16.840.1.113883.6.73 2017-01 A02AF01 magaldrate and antiflatulents 2.16.840.1.113883.6.73 2017-01 A02AF02 ordinary salt combinations and antiflatulents 2.16.840.1.113883.6.73 2017-01 A02AG Antacids with antispasmodics 2.16.840.1.113883.6.73 2017-01 A02AH Antacids with sodium bicarbonate 2.16.840.1.113883.6.73 2017-01 A02AX Antacids, other combinations 2.16.840.1.113883.6.73 2017-01 A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) 2.16.840.1.113883.6.73 2017-01 A02BA H2-receptor antagonists 2.16.840.1.113883.6.73 2017-01 A02BA01 cimetidine 2.16.840.1.113883.6.73 2017-01 A02BA02 ranitidine 2.16.840.1.113883.6.73 2017-01 A02BA03 famotidine 2.16.840.1.113883.6.73 2017-01 A02BA04 nizatidine 2.16.840.1.113883.6.73 2017-01 A02BA05 niperotidine 2.16.840.1.113883.6.73 2017-01 A02BA06 roxatidine 2.16.840.1.113883.6.73 2017-01 A02BA07 ranitidine bismuth citrate 2.16.840.1.113883.6.73 2017-01 A02BA08 lafutidine 2.16.840.1.113883.6.73 2017-01 A02BA51 cimetidine, combinations 2.16.840.1.113883.6.73 2017-01 A02BA53 famotidine, combinations 2.16.840.1.113883.6.73 2017-01 A02BB Prostaglandins 2.16.840.1.113883.6.73 2017-01 A02BB01 misoprostol 2.16.840.1.113883.6.73 2017-01 A02BB02 enprostil 2.16.840.1.113883.6.73 2017-01 A02BC Proton pump inhibitors 2.16.840.1.113883.6.73 2017-01 A02BC01 omeprazole 2.16.840.1.113883.6.73 2017-01 A02BC02 pantoprazole 2.16.840.1.113883.6.73 2017-01 A02BC03 lansoprazole 2.16.840.1.113883.6.73 2017-01 A02BC04 rabeprazole 2.16.840.1.113883.6.73 2017-01 A02BC05 esomeprazole 2.16.840.1.113883.6.73 2017-01 A02BC06 dexlansoprazole 2.16.840.1.113883.6.73 2017-01 A02BC07 dexrabeprazole 2.16.840.1.113883.6.73 2017-01 A02BC53 lansoprazole, combinations 2.16.840.1.113883.6.73 2017-01 A02BC54 rabeprazole, combinations 2.16.840.1.113883.6.73 2017-01 A02BD Combinations for eradication of Helicobacter pylori 2.16.840.1.113883.6.73 2017-01 A02BD01 omeprazole, amoxicillin and metronidazole 2.16.840.1.113883.6.73 2017-01 A02BD02 lansoprazole, tetracycline and metronidazole 2.16.840.1.113883.6.73 2017-01 A02BD03 lansoprazole, amoxicillin and metronidazole 2.16.840.1.113883.6.73 2017-01 A02BD04 pantoprazole, amoxicillin and clarithromycin 2.16.840.1.113883.6.73 2017-01 A02BD05 omeprazole, amoxicillin and clarithromycin 2.16.840.1.113883.6.73 2017-01 A02BD06 esomeprazole, amoxicillin and clarithromycin 2.16.840.1.113883.6.73 2017-01 A02BD07 lansoprazole, amoxicillin and clarithromycin 2.16.840.1.113883.6.73 2017-01 A02BD08 bismuth subcitrate, tetracycline and metronidazole 2.16.840.1.113883.6.73 2017-01 A02BD09 lansoprazole, clarithromycin and tinidazole 2.16.840.1.113883.6.73 2017-01 A02BD10 lansoprazole, amoxicillin and levofloxacin 2.16.840.1.113883.6.73 2017-01 A02BD11 pantoprazole, amoxicillin, clarithromycin and metronidazole © eHealth DSI eHDSI Solution Provider v2.2.1 Thu Jun 01 17:03:48 CEST 2017 Page 6 of 490 MTC epSOSActiveIngredient 2.16.840.1.113883.6.73 2017-01 A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) 2.16.840.1.113883.6.73 2017-01 A02BX01 carbenoxolone 2.16.840.1.113883.6.73 2017-01 A02BX02 sucralfate 2.16.840.1.113883.6.73 2017-01 A02BX03 pirenzepine 2.16.840.1.113883.6.73 2017-01 A02BX04 methiosulfonium chloride 2.16.840.1.113883.6.73 2017-01 A02BX05 bismuth subcitrate 2.16.840.1.113883.6.73 2017-01 A02BX06 proglumide 2.16.840.1.113883.6.73 2017-01 A02BX07 gefarnate 2.16.840.1.113883.6.73 2017-01 A02BX08 sulglicotide 2.16.840.1.113883.6.73 2017-01 A02BX09 acetoxolone 2.16.840.1.113883.6.73 2017-01 A02BX10 zolimidine 2.16.840.1.113883.6.73 2017-01 A02BX11 troxipide 2.16.840.1.113883.6.73 2017-01 A02BX12 bismuth subnitrate 2.16.840.1.113883.6.73 2017-01 A02BX13 alginic acid 2.16.840.1.113883.6.73 2017-01 A02BX51 carbenoxolone, combinations excl.